HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bryan A. Whitson Michael A. Maddaus Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Groth, S. S. Articles by Maddaus, M. A. Search for Related Content PubMed Articles by Groth, S. S. Articles by Maddaus, M. A. Related Collections Esophagus - cancer

J Thorac Cardiovasc Surg 2010;139:612-620
© 2010 The American Association for Thoracic Surgery

General Thoracic Surgery

Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: Data from the Surveillance Epidemiology and End Results database

^a University of Minnesota Department of Surgery, Division of Thoracic Foregut Surgery, Minneapolis, Minn
^b University of Minnesota School of Public Health, Division of Health Policy and Management, Minneapolis, Minn
^c University of Minnesota Cancer Center, Minneapolis, Minn

Received for publication November 12, 2008; revisions received May 27, 2009; accepted for publication July 6, 2009.

^_* Address for reprints: Michael A. Maddaus, MD, University of Minnesota Department of Surgery, Section of Thoracic and Foregut Surgery, MMC 207, 420 Delaware St SE, Minneapolis, MN 55455. (Email: madda001{at}umn.edu).

Objective: We used a population-based cancer registry to examine the association between lymph node counts and mortality to determine the minimum number of lymph nodes that should be examined as part of esophageal resection.

Methods: Using the Surveillance Epidemiology and End Results database, we identified patients who had an esophagectomy for invasive esophageal carcinoma from 1988 through 2005 and who had a known number of lymph nodes examined pathologically. After stratifying patients (0, 1–11, 12–29, and 30 or more lymph nodes examined) based on a recursive partitioning analysis, we assessed the association between lymph nodes counts and mortality using the Kaplan-Meier method. To adjust for potential confounding covariates, we used a Cox proportional hazards regression model.

Results: Of the patients in the Surveillance Epidemiology and End Results database with esophageal cancer, 4882 met our inclusion criteria. We noted a significant difference between the lymph node groups with regards to unadjusted all-cause (P < .0001) and cancer-specific mortality (P = .004). After adjusting for cancer registry, patient factors, tumor characteristics, and timing of radiation therapy, we noted a significant difference between the lymph node groups with regards to all-cause and cancer-specific mortality. Compared with patients who had no lymph node evaluation, only patients who had more than 12 lymph nodes examined had a significant improvement in mortality; patients who had 30 or more lymph nodes examined had significantly lower mortality rates than the other groups.

Conclusion: To maximize all-cause and cancer-specific survival, esophageal cancer patients should have at least 30 lymph nodes examined pathologically as part of esophageal resection.

This article has been cited by other articles:

				B. A. Whitson, S. S. Groth, R. S. Andrade, M. A. Maddaus, E. B. Habermann, and J. D'Cunha Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Ann. Thorac. Surg., December 1, 2011; 92(6): 1943 - 1950. [Abstract] [Full Text] [PDF]

				R. E. Glasgow, D. H. Ilson, J. A. Hayman, H. Gerdes, M. F. Mulcahy, and J. A. Ajani Modern Approaches to Localized Cancer of the Esophagus J Natl Compr Canc Netw, August 1, 2011; 9(8): 902 - 911. [Abstract] [Full Text] [PDF]